Bill Summary
The "Flu Vaccine Act" is a bill that has been proposed in the United States Congress to conduct or fund further research for the development of a universal influenza vaccine. The purpose of this bill is to provide funding for the Director of the National Institute of Allergy and Infectious Diseases to conduct or support comprehensive research in this area. The bill also authorizes an appropriation of $200,000,000 for each fiscal year between 2020 and 2024 to carry out this research. The goal of this legislation is to create a universal influenza vaccine that will provide protection against all strains of the flu, rather than needing to be updated each year.
Possible Impacts
1. Availability of a universal influenza vaccine: The passing of this bill could potentially lead to the development of a universal influenza vaccine, making it more readily available to people and potentially reducing the number of cases and deaths from the flu.
2. Impact on public health: The allocation of $200,000,000 for research on a universal influenza vaccine could have a significant impact on public health. If successful, the vaccine could help prevent the spread of the flu and improve overall health outcomes for individuals and communities.
3. Economic implications: The creation of a universal influenza vaccine could have economic implications for individuals and the country as a whole. By reducing the number of flu cases, it could potentially save individuals and the government money on healthcare costs. It could also have an impact on the pharmaceutical industry, as companies may need to adjust their production and marketing strategies.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1371 Introduced in House (IH)]
<DOC>
116th CONGRESS
1st Session
H. R. 1371
To conduct or support further comprehensive research for the creation
of a universal influenza vaccine.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 26, 2019
Ms. DeLauro (for herself, Ms. Castor of Florida, Mr. Cohen, Ms. Jackson
Lee, Mrs. Carolyn B. Maloney of New York, and Ms. Norton) introduced
the following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To conduct or support further comprehensive research for the creation
of a universal influenza vaccine.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Flu Vaccine Act''.
SEC. 2. RESEARCH FOR THE CREATION OF A UNIVERSAL INFLUENZA VACCINE.
(a) In General.--The Director of the National Institute of Allergy
and Infectious Diseases shall conduct or support comprehensive research
for the creation of a universal influenza vaccine.
(b) Authorization of Appropriations.--To carry out this section,
there are authorized to be appropriated $200,000,000 for each of fiscal
years 2020 through 2024.
<all>